Zobrazeno 1 - 6
of 6
pro vyhledávání: '"W Quinn O'Neill"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Background Patients with human papillomavirus (HPV+) head and neck squamous cell carcinoma (HNSCC) have superior prognoses compared with patients with HPV− HNSCC and strategies for treatment de-escalation are under investigation for the HPV+ settin
Externí odkaz:
https://doaj.org/article/a066994fb4fd45fcbb5483e6ff31f935
Autor:
W. Quinn O’Neill, Xiujie Xie, Shanying Gui, Heping Yu, Jacqueline Davenport, Thomas Cartwright, Marta Storl-Desmond, Esther Ryu, Ernest R. Chan, Shufen Cao, Pingfu Fu, Theodoros N. Teknos, Quintin Pan
Publikováno v:
Cancers; Volume 14; Issue 2; Pages: 282
Cancers, Vol 14, Iss 282, p 282 (2022)
Cancers
Cancers, Vol 14, Iss 282, p 282 (2022)
Cancers
Simple Summary A critical need for optimal management of human papillomavirus-associated head and neck squamous cell carcinoma (HPV+ HNSCC) patients is the development of therapeutic strategies to exploit the inherent vulnerabilities of this unique d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d827c94e8aadb868131db70b3d4e9019
Autor:
W. Quinn O’Neill, Jay Wasman, Nicole Fowler, Shawn Li, Lizabeth Lukesic, Quintin Pan, Kate Chatfield-Reed, Ravi Kyasram, Pierre Lavertu, Theodoros N. Teknos, Jason Thuener, John Shanahan, Brandon Vu, Rod Rezaee, Blake Szelesety
Publikováno v:
JCO Oncol Pract
PURPOSE: Human papilloma virus–positive (HPV+) oropharyngeal squamous cell carcinoma (OPSCC), diagnosed with p16 immunohistochemistry, is associated with favorable prognosis; however, this connection was established using European American (EA)–s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfa1c3d02792e179c69fb77c5c5dfcb2
https://pubmed.ncbi.nlm.nih.gov/33974822
https://pubmed.ncbi.nlm.nih.gov/33974822
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundPatients with human papillomavirus (HPV+) head and neck squamous cell carcinoma (HNSCC) have superior prognoses compared with patients with HPV− HNSCC and strategies for treatment de-escalation are under investigation for the HPV+ setting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b5b60910151536ae0d3a662a8b95cfd
https://jitc.bmj.com/content/9/3/e001259.full
https://jitc.bmj.com/content/9/3/e001259.full
Autor:
Kate Clancy, Rod Rezaee, Pierre Lavertu, Theodoros N. Teknos, Nicole Fowler, Hira Shaikh, Shawn Li, Trisha Wise-Draper, Anant Madabhushi, W. Quinn O’Neill, Quintin Pan, Monaliben Patel, Chelsea S. Hamill, Eric Vick, Jay Wasman, Jason Thuener, Shanying Gui, Brandon Vu, Kyunghee Burkitt
Publikováno v:
Cancers
Volume 13
Issue 19
Cancers, Vol 13, Iss 4861, p 4861 (2021)
Volume 13
Issue 19
Cancers, Vol 13, Iss 4861, p 4861 (2021)
In head and neck squamous cell carcinoma (HNSCC), anti-PD-1 inhibitors are approved for recurrent/metastatic (R/M) disease and anticipated to expand to other indications. The impact of p16 status and anatomical site on overall survival (OS) in immuno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a1b5585d1a4950b8e80c64be05b469b
https://doi.org/10.3390/cancers13194861
https://doi.org/10.3390/cancers13194861
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.